Smaller gain, caution leads the trade
Amgen slips 2.9% as buying pressure fades in the week's final session
Smaller gain, caution leads the trade
Our view last week
Amgen is in week 3 of a buy signal and already up 5.34% since entry. The confirmation week, though, closed lower and signal strength fades to 29 out of 100. The stock ranks 117th among the 125 US stock buys currently open: a case to watch, not to reinforce.
This week's summary
Amgen's buy signal is in its fourth week, and the week just closed changed the rhythm: the stock gave back 2.9%, with buyer dominance sliding hard and sellers ruling the last candle. The weekly structure holds up though — moving averages aligned, price above the Ichimoku cloud — and the MACD keeps improving. The trade's gain has narrowed to 2.3% since entry, and signal strength stays modest, at 33 out of 100: caution leads the trade.
IQS Phase
64
ordinary
Signal Strength
33
medium · weak
Sizing
REDUCED
Ranking
#117 / 129
US stocks in progress
Trade P&L %
+2.31%
from signal to today
restricted Platinum content